Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C
Huiying Rao(Peking University), Anna S. Lok(University of Michigan), Lai Wei(Tongji University), Bo Feng(Peking University), Elizabeth Wu(University of Michigan), Huixin Liu(Peking University), Ming Yang(Peking University), Ran Fei(Peking University), Andy Lin(University of Michigan), Robert J. Fontana(University of Michigan)
Cited by 4
Related Papers
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
|Hepatology|2003|4.3k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Management of hepatitis B: 2000—Summary of a workshop
|Gastroenterology|2001|786
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Management of hepatitis B
|Hepatology|2007|635